AmpliTech Group (AMPG) director adds shares via rights offer
Rhea-AI Filing Summary
AmpliTech Group director Daniel Richard Mazziota reported acquiring 2,000 units on January 14, 2026 through the company’s rights offering. Each unit consisted of 2,000 shares of common stock at $4 per share, plus Series A and Series B rights to buy additional common shares.
The transaction gave him 2,000 Series A Rights with a $5 exercise price expiring on July 18, 2026, and 2,000 Series B Rights with a $6 exercise price expiring on November 20, 2026, each tied to 2,000 underlying common shares. Following the purchase, he beneficially owned 264,900 shares of AmpliTech common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Series A Rights | 2,000 | $0.00 | $0.00 |
| Grant/Award | Series B Rights | 2,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $4.00 | $8K |
Footnotes (1)
- F1. On January 14, 2026, the Reporting Person acquired 2,000 Units consisting of (i) 2,000 shares of common stock, (ii) Series A Rights to purchase 2,000 shares of common stock and (iii) Series B Rights to purchase 2,000 shares of common stock in connection with the exercise of unit subscription rights issued to the Reporting Person and other stockholders and eligible warrantholders on a pro rata basis in the Issuer's Rights Offering. The unit subscription rights were exempt from reporting under Rule 16a-9(b).
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did AmpliTech Group (AMPG) report?
AmpliTech Group reported that director Daniel Richard Mazziota acquired 2,000 units on January 14, 2026 in connection with the company’s rights offering.
What derivative rights did the AmpliTech (AMPG) director receive in this Form 4 filing?
He received 2,000 Series A Rights with a $5 exercise price and 2,000 Series B Rights with a $6 exercise price, each right tied to 2,000 underlying common shares.
When do the AmpliTech (AMPG) Series A and Series B Rights expire?
The Series A Rights expire on July 18, 2026, and the Series B Rights expire on November 20, 2026, according to the filing.
Was the AmpliTech (AMPG) director’s acquisition part of a rights offering?
Yes. The footnote explains that the 2,000 units were acquired by exercising unit subscription rights issued on a pro rata basis in AmpliTech’s rights offering.